Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Blood stem cell growth factor reverses memory decline in mice

Blood stem cell growth factor reverses memory decline in mice

July 02, 2009

A human growth factor that stimulates blood stem cells to proliferate in the bone marrow reverses memory impairment in mice genetically altered to develop Alzheimer's disease, researchers at the University of South Florida and James A. Haley Hospital found. The granulocyte-colony stimulating factor (GCSF) significantly reduced levels of the brain-clogging protein beta amyloid deposited in excess in the brains of the Alzheimer's mice, increased the production of new neurons and promoted nerve cell connections.

The findings are reported online in Neuroscience and are scheduled to appear in the journal's print edition in August.




GCSF is a blood stem cell growth factor or hormone routinely administered to cancer patients whose blood stem cells and white blood cells have been depleted following chemotherapy or radiation. GCSF stimulates the bone marrow to produce more white blood cells needed to fight infection. It is also used to boost the numbers of stem cells circulating in the blood of donors before the cells are harvested for bone marrow transplants. Advanced clinical trials are now investigating the effectiveness of GCSF to treat stroke, and the compound was safe and well tolerated in early clinical studies of ischemic stroke patients.

"GCSF has been used and studied clinically for a long time, but we're the first group to apply it to Alzheimer's disease," said USF neuroscientist Juan Sanchez-Ramos, MD, PhD, the study's lead author. "This growth factor could potentially provide a powerful new therapy for Alzheimer's disease - one that may actually reverse disease, not just alleviate symptoms like currently available drugs."

The researchers showed that injections under the skin of filgrastim (Neupogen®) -- one of three commercially available GCSF compounds -- mobilized blood stem cells in the bone marrow and neural stem cells within the brain and both of these actions led to improved memory and learning behavior in the Alzheimer's mice. "The beauty in this less invasive approach is that it obviates the need for neurosurgery to transplant stem cells into the brain," Dr. Sanchez-Ramos said.

Based on the promising findings in mice, the Alzheimer's Drug Discovery Foundation is funding a pilot clinical trial at USF's Byrd Alzheimer's Center. The randomized, controlled trial, led by Dr. Sanchez-Ramos and Dr. Ashok Raj, will test the safety and effectiveness of filgrastim in 12 patients with mild to moderate Alzheimer's disease

The researchers worked with 52 elderly mice, equivalent to the human ages of 60 to 80 years. About half (24) were mice genetically altered to develop symptoms mimicking Alzheimer's disease by the time they reach 5-months old. The others (28 normal, or non-Alzheimer's, mice) were not. The researchers confirmed through a series of tests that the Alzheimer's mice were memory impaired before beginning the experiments.

Some mice were treated for three weeks with injections of the GCSF compound filgrastim. At the end of study, the Alzheimer's mice treated with GCSF demonstrated clearly improved memory, performing as well on behavioral tests as their non-Alzheimer's counterparts. The Alzheimer's mice administered saline injections instead of GCSF continued to perform poorly. GCSF treatment did not boost the already excellent memory performance demonstrated by the non-Alzheimer's mice tested before the study began.

Further experiments showed that the size and extent of beta amyloid deposited in the brains of the Alzheimer's mice was significantly less in those treated with GCSF. Depending on their ages, mice treated with GCSF had a 36 to 42-percent reduction in beta amyloid, the protein considered a major culprit in the development of Alzheimer's disease.

GCSF reduced the burden of beta amyloid deposited in the brains of the Alzheimer's mice by several means, the researchers found. One was by recruiting reinforcements to clear beta amyloid accumulating abnormally in the brain. The growth factor prodded bone-marrow derived microglia outside the brain to join forces with the brain's already-activated microglia in eliminating the Alzheimer's protein from the brain. Microglia are brain cells that act as the central nervous system's main form of immune defense. Like molecular "Pac-men," they rush to the defense of damaged or inflamed areas to gobble up toxic substances.

The growth factor also appeared to increase the production of new neurons in the area of the brain (hippocampus) associated with memory decline in Alzheimer's disease and to form new neural connections.

"The concept of using GCSF to harness bone marrow-derived cells for Alzheimer's therapy is exciting and the findings in mice are promising, but we still need to prove that this works in humans," said Dr. Raj, a physician researcher at the Byrd Alzheimer's Center at USF Health.

University of South Florida Health



Related Blood Stem Cells Current Events and Blood Stem Cells News Articles Blood Stem Cells Current Events and Blood Stem Cells News RSS Blood Stem Cells Current Events and Blood Stem Cells News RSS
The use of stem cells in regenerative medicine may also be detrimental for health
The use of stem cells in regenerative medicine is not always beneficial for human health, it may even be harmful according to a work done by the University of Granada and University of León. Scientists have demonstrated that transplantation of human mononuclear cells isolated from umbilical cord blood exerted a deleterious effect in rats with liver cirrhosis.

Scientists successfully reprogram blood cells
Researchers have transplanted genetically modified hematopoietic stem cells into mice so that their developing red blood cells produce a critical lysosomal enzyme -preventing or reducing organ and central nervous system damage from the often-fatal genetic disorder Hurler's syndrome.

Blood counts are clues to human disease
A new genome-wide association study published today in Nature Genetics begins to uncover the basis of genetic variations in eight blood measurements and the impact those variants can have on common human diseases.

Governor recognizes stem cell research at Einstein
Albert Einstein College of Medicine of Yeshiva University hosted a roundtable discussion on stem cell research with New York Governor David A. Paterson today.

Reactive oxygen in fruit flies acts as a cell signalling mechanism for immune response
For years, health conscious people have been taking antioxidants to reduce the levels of reactive oxygen in their blood and prevent the DNA damage done by free radicals, which are the result of oxidative stress. But could excessive use of antioxidants deplete our immune systems?

Private umbilical cord banking not cost-effective, UCSF research shows
Private cord blood banking is not cost-effective because it costs an additional $1,374,246 per life-year gained, according to a new analysis by UCSF researchers.

Master gene that switches on disease-fighting cells identified by scientists
The master gene that causes blood stem cells to turn into disease-fighting 'Natural Killer' (NK) immune cells has been identified by scientists, in a study published in Nature Immunology today.

UF scientists program blood stem cells to become vision cells
University of Florida researchers were able to program bone marrow stem cells to repair damaged retinas in mice, suggesting a potential treatment for one of the most common causes of vision loss in older people.

MGH study identifies first molecular steps to childhood leukemia
A Massachusetts General Hospital (MGH)-based research team has identified how a chromosomal abnormality known to be associated with acute lymphoblastic leukemia (ALL) - the most common cancer in children - initiates the disease process.

Trimming the fat boosts blood recovery after marrow transplant
Seeking ways to improve blood recovery after chemotherapy or bone marrow transplant, researchers at Children's Hospital Boston have discovered that fat cells, which accumulate in bone marrow as people age, inhibit the marrow's ability to produce new blood cells.
More Blood Stem Cells Current Events and Blood Stem Cells News Articles
Bone Marrow and Blood Stem Cell Transplants: A Guide For Patients

Bone Marrow and Blood Stem Cell Transplants: A Guide For Patients
by Susan Stewart (Author)

Bone Marrow and Stem Cell Transplants: A Guide for Patients is the next generation of Susan K. Stewart's groundbreaking 1992 book Bone Marrow Transplants: A Book of Basics for Patients. This new 228 paage guide combines solid medical information with the voices of people who have been through a transplant.

Comprehensive and easy-to-read, Bone Marrow and Blood Stem Cell Transplants: A Guide for Patients is a goldmine of information for people considering a transplant with donor marrow or stem cells.

The book covers a variety of topics and issues such as; History of Transplantation

Nuts and Bolts of a Transplant
Choosing a Transplant Center
Finding a Stem Cell Donor
Being a Donor
Emotional/Psychological Considerations
When Your Child Needs a...

ABC News Nightline Banking on your Future

ABC News Nightline Banking on your Future

Storing umbilical cord blood is a growing phenomenon. Private cord blood banks across the country are providing storage for thousands of parents and there are a lot of parents out there who think they will be letting their children down if they don't participate. The question is, how useful are they? And if storing cord blood is a useful thing to do, should there be more public cord blood banks accessible to everyone, including those who might not be able to afford private banks? ABC News will examine the science and the social implications of this new trend in medicine. Is it an example of a scientific breakthrough vital to all, or an example of 'boutique medicine' dividing those with means from those without?

Anchor: Ted Koppel

Airdate: 10/4/2005

This product is manufactured on...

Blood And Marrow Stem Cell Transplantation: Principles, Practice, And Nursing Insights

Blood And Marrow Stem Cell Transplantation: Principles, Practice, And Nursing Insights
by Susan Ezzone (Author), Kim Schmit-pokorny (Editor)

Blood and Marrow Stem Cell Transplantation, Third Edition serves as a convenient reference for oncology nurses caring for blood and marrow stem cell transplantation recipients. The Third Edition has been updated and revised to reflect the most current research related to the past, present, and future of blood and marrow stem cell transplants. This resource covers everything from preparing for transplantation, to recovery-related issues and delayed outcomes. Basic background information on transplantation procedures and processes are provided, along with in-depth coverage of pulmonary, cardiac, renal and hepatic, neurologic, and hematologic effects. A chapter devoted to controversial ethical issues is also provided. Blood and Marrow Stem Cell Transplantation, Third Edition...

  Discover the Power of Stem Cells
Also With: various (Primary Contributor)



Blood Stem Cell Transplantation

Blood Stem Cell Transplantation
by James O Armitage (Author)

Laboratoire de Greffe de Moelle Universite, Cedex, France. An overview of the scientific and technical advances that have been made. Discusees the clinical applications and results of transplantations with blood-derived stem cells. 34 contributors, 18 U.S.

Clinical Bone Marrow and Blood Stem Cell Transplantation

Clinical Bone Marrow and Blood Stem Cell Transplantation
by Kerry Atkinson (Editor), Richard Champlin (Editor), Jerome Ritz (Editor), Willem E. Fibbe (Editor), Per Ljungman (Editor), Malcom K. Brenner (Editor)

The text of this new third edition is significantly revised and updated with 124 chapters on all aspects of autologous, syngeneic, and allogeneic transplantation. Thoroughly referenced through 2003 with a final "breaking news" chapter from this rapidly evolving field, the authoritative and practical text is an essential resource for hematologists, oncologists, and transplant specialists. Second Edition Hb (1999): 0-521-62288-3

  Targeting blood stem cells.: An article from: Canadian Chemical News
by Thomson Gale (Publisher)

This digital document is an article from Canadian Chemical News, published by Thomson Gale on January 1, 2006. The length of the article is 486 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Targeting blood stem cells.
Publication: Canadian Chemical News (Magazine/Journal)
Date: January 1, 2006
Publisher: Thomson Gale
Volume: 58 Issue: 1 Page: 5(1)

Distributed by Thomson Gale

Cord Blood: Establishing a National Hematopoietic Stem Cell Bank Program

Cord Blood: Establishing a National Hematopoietic Stem Cell Bank Program
by Committee on Establishing a National Cord Blood Stem Cell Bank Program (Author), Emily Ann Meyer (Editor), Kathi Hanna (Editor), Kristine Gebbie (Editor)

With the potential for self-renewal and differentiation, the possibilities for stem cells are enormous. One specific type of stem cell, the hematopoietic progenitor cell (HPC), which is derived from umbilical cord blood (as well as adult bone marrow and mobilized peripheral blood), holds particular promise. To make the most of these HPCs, the Institute of Medicine was asked to consider the optimal structure for a national cord blood program and to address pertinent issues related to maximizing the potential of stem cell technology. "Cord Blood: Establishing a National Hematopoietic Stem Cell Bank Program" examines: the role of cord blood in stem cell transplantation; the current status of blood banks already in existence; the optimal structure for the cord blood program; the current use...

  Peripheral Blood Stem Cells
by Douglas M. Smith (Author), Douglas M. Smith (Editor), Ronald A. Sacher (Editor), Leigh C. Jefferies (Editor)



  Advances in cord blood stem cell transplants prompts bi-partisan effort to establish national network.: An article from: Transplant News
by Jim Warren (Author)

This digital document is an article from Transplant News, published by Transplant Communications, Inc. on October 31, 2003. The length of the article is 824 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Advances in cord blood stem cell transplants prompts bi-partisan effort to establish national network.
Author: Jim Warren
Publication: Transplant News (Newsletter)
Date: October 31, 2003
Publisher: Transplant Communications, Inc.
Volume: 13 Issue: 20

Distributed by Thomson...

© 2009 BrightSurf.com